Sci-Tech Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.

Press releases published on August 3, 2026

Aug. 3, 2026

Softrax Named to MGI Research's 2026 Agile Billing Top 50 Buyer's Guide, Leader in All Four MarketLens™ Rankings

Indeterminate EIN Presswire

Aug. 3, 2026

Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Five Gold Standards for Enterprise Structured Cabling and Network Infrastructure in 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Teads Files Lawsuit Against Google Seeking Financial Damages Following Federal Court Antitrust Ruling

Indeterminate GlobeNewswire

Aug. 3, 2026

Parental Alienation Evidence: What Family Courts Actually Accept

Indeterminate GlobeNewswire

Aug. 3, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Aug. 3, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Technical Procurement Guide to a Professional Titanium Seamless Pipe Manufacturer with TUV Standards

Indeterminate EIN Presswire

Aug. 3, 2026

Global Leading Metal Composite Material Solutions: TGTY’s Industry Insights on Optimizing Costs in Heavy Industry

Indeterminate EIN Presswire

Aug. 3, 2026

3D Systems Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Seer to Participate in the Canaccord Genuity 46th Annual Growth Conference 

Indeterminate GlobeNewswire

Aug. 3, 2026

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards

Indeterminate GlobeNewswire

Aug. 3, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 3, 2026

Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast

Indeterminate GlobeNewswire

Aug. 3, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire